WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis

Cochrane Database Syst Rev. 2015 Jun 5;2015(6):CD004193. doi: 10.1002/14651858.CD004193.pub3.

Abstract

This review has been withdrawn for the following reasons:

a review author contravenes Cochrane's Commercial Sponsorship Policy. This policy ensures the independence of Cochrane reviews by making sure that there is no bias associated with commercial conflicts of interest in the conduct of Cochrane reviews. The author was employed by the biopharmaceutical company AstraZeneca and cannot say with certainty that the company did not produce or have any financial interest in the interventions in this review

the review is substantially out of date

To view the published versions of this article, please click the 'Other versions' tab.

The editorial group responsible for this previously published document have withdrawn it from publication.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Cholinergic Antagonists / adverse effects
  • Cholinergic Antagonists / therapeutic use*
  • Conflict of Interest
  • Humans
  • Multiple Sclerosis / complications*
  • Randomized Controlled Trials as Topic
  • Urinary Bladder, Overactive / drug therapy*
  • Urinary Bladder, Overactive / etiology

Substances

  • Cholinergic Antagonists